ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01928225
Recruitment Status : Unknown
Verified May 2016 by Cynthia S Firnhaber, University of Witwatersrand, South Africa.
Recruitment status was:  Enrolling by invitation
First Posted : August 23, 2013
Last Update Posted : May 13, 2016
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Cynthia S Firnhaber, University of Witwatersrand, South Africa

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : March 2017